BOLD
Boundless Bio·NASDAQ
--
--(--)
--
--(--)
5.19 / 10
Netural
Analyst coverage is minimal with only one active analyst issuing a Strong Buy rating; consensus is neutral. Fund flow metrics, however, score 7.27/10, showing overall positive capital movement, though Small, Medium, and Large patterns are negative. This divergence between bullish analyst sentiment and mixed fund flows adds uncertainty to the stock's near-term direction.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-08-11
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of BOLD?
- BOLD holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.19/10 (Netural).
